357 related articles for article (PubMed ID: 33185730)
1. Development of cytomegalovirus retinitis after negative conversion of cytomegalovirus antigenemia due to systemic antiviral therapy.
Suzuki K; Namba K; Mizuuchi K; Iwata D; Ito T; Hase K; Kitaichi N; Ishida S
Graefes Arch Clin Exp Ophthalmol; 2021 Apr; 259(4):971-978. PubMed ID: 33185730
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus antigenemia in acquired immunodeficiency syndrome patients with untreated cytomegalovirus retinitis.
Pannuti CS; Kallás EG; Muccioli C; Roland RK; Ferreira EC; Bueno SM; Do Canto CL; Villas Boas LS; Belfort Júnior R
Am J Ophthalmol; 1996 Dec; 122(6):847-52. PubMed ID: 8956639
[TBL] [Abstract][Full Text] [Related]
3. Management of Ganciclovir Resistant Cytomegalovirus Retinitis in a Solid Organ Transplant Recipient: A Review of Current Evidence and Treatment Approaches.
Fu L; Santhanakrishnan K; Al-Aloul M; Jones NP; Steeples LR
Ocul Immunol Inflamm; 2020 Oct; 28(7):1152-1158. PubMed ID: 31621449
[No Abstract] [Full Text] [Related]
4. Continued decline of aqueous interleukin-8 after multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis.
Wang B; Tian B; Tao Y; Hou J; Zhao XT; Li XX
J Ocul Pharmacol Ther; 2014 Sep; 30(7):587-92. PubMed ID: 24874926
[TBL] [Abstract][Full Text] [Related]
5. Aqueous humor immune factors and cytomegalovirus (CMV) levels in CMV retinitis through treatment - The CRIGSS study.
Iyer JV; Agrawal R; Yeo TK; Gunasekeran DV; Balne PK; Lee B; Au VB; Connolly J; Teoh SC
Cytokine; 2016 Aug; 84():56-62. PubMed ID: 27239802
[TBL] [Abstract][Full Text] [Related]
6. Multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis after stem-cell transplantation.
Miao H; Tao Y; Jiang YR; Li XX
Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1829-33. PubMed ID: 23665863
[TBL] [Abstract][Full Text] [Related]
7. Recurrent CMV retinitis in a non-HIV patient with drug-resistant CMV.
Hoang QV; Simon DM; Kumar GN; Oh F; Goldstein DA
Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):737-40. PubMed ID: 20094728
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis.
Walmsley SL; Raboud J; Angel JB; Mazzulli T; Shen S; Casciaro L; Young CD; Moussa G; Gough K; Rachlis A; Hopkins J
HIV Clin Trials; 2006; 7(1):1-9. PubMed ID: 16632459
[TBL] [Abstract][Full Text] [Related]
9. Treating HIV-associated cytomegalovirus retinitis with oral valganciclovir and intra-ocular ganciclovir by primary HIV clinicians in southern Myanmar: a retrospective analysis of routinely collected data.
Murray J; Hilbig A; Soe TT; Ei WLSS; Soe KP; Ciglenecki I
BMC Infect Dis; 2020 Nov; 20(1):842. PubMed ID: 33187478
[TBL] [Abstract][Full Text] [Related]
10. Abnormal levels of aqueous humor trace elements in patients with cytomegalovirus retinitis.
Zhou Y; Hong F; Wang X; Feng J; Zhu D; Xu Y; Tao Y
Eye (Lond); 2019 Oct; 33(10):1606-1612. PubMed ID: 31065104
[TBL] [Abstract][Full Text] [Related]
11. The Predictive Value of Interleukin-8 in the Development of Cytomegalovirus Retinitis in HIV-Negative Patients.
Qian Z; Fan H; Chen X; Tao Y
Ophthalmic Res; 2022; 65(3):287-292. PubMed ID: 33326958
[TBL] [Abstract][Full Text] [Related]
12. [Influent factors for treating procedure of cytomegalovirus retinitis after allogeneic bone marrow hematopoietic stem cell transplantation].
Miao H; Hou J
Zhonghua Yan Ke Za Zhi; 2017 Oct; 53(10):740-745. PubMed ID: 29050186
[No Abstract] [Full Text] [Related]
13. Intravitreal ganciclovir for neonatal cytomegalovirus-associated retinitis: a case report.
Oschman A; Murthy V; Kollipara R; Kenneth Lord R; Oluola O
J Perinatol; 2013 Apr; 33(4):329-31. PubMed ID: 23536045
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes of reduced-dose intravitreal ganciclovir for cytomegalovirus retinitis.
Choopong P; Vivittaworn K; Konlakij D; Thoongsuwan S; Pituksung A; Tesavibul N
BMC Infect Dis; 2016 Apr; 16():164. PubMed ID: 27090644
[TBL] [Abstract][Full Text] [Related]
15. CMV retinitis after cessation of ganciclovir therapy for CMV antigenemia in an unrelated BMT recipient.
Suzuki N; Kudoh T; Mizue N; Watanabe J; Ikehata M; Tateno M; Ooguro H; Chiba S
Bone Marrow Transplant; 1998 Nov; 22(9):931-2. PubMed ID: 9827825
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study.
Boeckh M; Gooley TA; Myerson D; Cunningham T; Schoch G; Bowden RA
Blood; 1996 Nov; 88(10):4063-71. PubMed ID: 8916975
[TBL] [Abstract][Full Text] [Related]
17. Cytomegaloviral Retinitis in a Heart Transplant Patient: Case Report and Review of the Literature.
Janicka-Maszke Z; Konopa J; Ślizień M; Glasner P; Chamienia A; Dębska-Ślizień A; Michalska-Małecka K; Glasner L
Transplant Proc; 2022 May; 54(4):1158-1166. PubMed ID: 35760629
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of treatment administration strategies of ganciclovir for cytomegalovirus retinitis in HIV/AIDS patients in Thailand: a simulation study.
Teerawattananon K; Iewsakul S; Yenjitr C; Ausayakhun S; Yenjitr W; Mugford M; Teerawattananon Y
Pharmacoeconomics; 2007; 25(5):413-28. PubMed ID: 17488139
[TBL] [Abstract][Full Text] [Related]
19. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
[TBL] [Abstract][Full Text] [Related]
20. Half-dose ganciclovir preemptive treatment of cytomegalovirus infection after pediatric allogeneic hematopoietic stem cell transplantation.
Ju HY; Kang HJ; Hong CR; Lee JW; Kim H; Park KD; Shin HY; Park JD; Choi EH; Lee HJ; Ahn HS
Transpl Infect Dis; 2016 Jun; 18(3):396-404. PubMed ID: 27041364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
